Drug: Tapentadol: chronic pain clinical trials
Registry records that list "Drug: Tapentadol" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
5
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
5 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Tapentadol vs Tramadol in Arthroscopic Rotator Cuff Repair NCT07779473 | Active, not recruiting | Greece | University of Thessaly | 2026-07-01 | |
| Tapentadol vs Tramadol in Total Knee Arthroplasty NCT06269770 | Unknown status | Phase 4 | Greece | University of Thessaly | 2023-05-01 |
| Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain. NCT01725087 | Completed | Phase 2 | Austria, Belgium, Denmark, Finland and 7 more | Tris Pharma, Inc. | 2012-11 |
| A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia NCT01124617 | Completed | Phase 2 | Japan | Janssen Pharmaceutical K.K. | 2010-06 |
| Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular Analgesic NCT00983073 | Completed | Phase 3 | France, Germany, Poland, Spain and 1 more | Grünenthal GmbH | 2009-09 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.